Literature DB >> 29267980

The trophic life cycle stage of Pneumocystis species induces protective adaptive responses without inflammation-mediated progression to pneumonia.

Heather M Evans1, Beth A Garvy1,2.   

Abstract

Pneumocystis species are fungal pathogens that cause pneumonia in immunocompromised hosts. Lung damage during Pneumocystis pneumonia is predominately due to the inflammatory immune response. Pneumocystis species have a biphasic life cycle. Optimal innate immune responses to Pneumocystis species are dependent on stimulation with the cyst life cycle stage. Conversely, the trophic life cycle stage broadly suppresses proinflammatory responses to multiple pathogen-associated molecular patterns (PAMPs), including β-1,3-glucan. Little is known about the contribution of these life cycle stages to the development of protective adaptive responses to Pneumocystis infection. Here we report that CD4+ T cells primed in the presence of trophic forms are sufficient to mediate clearance of trophic forms and cysts. In addition, primary infection with trophic forms is sufficient to prime B-cell memory responses capable of clearing a secondary infection with Pneumocystis following CD4+ T cell depletion. While trophic forms are sufficient for initiation of adaptive immune responses in immunocompetent mice, infection of immunocompromised recombination-activating gene 2 knockout (RAG2-/-) mice with trophic forms in the absence of cysts does not lead to the severe weight loss and infiltration of innate immune cells associated with the development of Pneumocystis pneumonia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29267980      PMCID: PMC6455891          DOI: 10.1093/mmy/myx145

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  40 in total

1.  Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii.

Authors:  J E Shellito; C Tate; S Ruan; J Kolls
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

Review 2.  Immunopathogenesis of Pneumocystis carinii pneumonia.

Authors:  Francis Gigliotti; Terry W Wright
Journal:  Expert Rev Mol Med       Date:  2005-11-14       Impact factor: 5.600

3.  Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

Authors:  T W Wright; F Gigliotti; J N Finkelstein; J T McBride; C L An; A G Harmsen
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection.

Authors:  Xiaowen L Rudner; Kyle I Happel; Erana A Young; Judd E Shellito
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

5.  Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.

Authors:  Kerry M Empey; Melissa Hollifield; Kevin Schuer; Francis Gigliotti; Beth A Garvy
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.

Authors:  Frances E Lund; Melissa Hollifield; Kevin Schuer; J Louise Lines; Troy D Randall; Beth A Garvy
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

7.  Pneumocystis carinii enhances soluble mannose receptor production by macrophages.

Authors:  I P Fraser; K Takahashi; H Koziel; B Fardin; A Harmsen; R A Ezekowitz
Journal:  Microbes Infect       Date:  2000-09       Impact factor: 2.700

8.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.

Authors:  Frances E Lund; Kevin Schuer; Melissa Hollifield; Troy D Randall; Beth A Garvy
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

10.  Activation of the respiratory burst by Pneumocystis carinii. Efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin.

Authors:  Alex L Laursen; Niels S Obel; Uffe Holmskov; Jens C Jensenius; El Moukhtar Aliouat; Paul L Andersen
Journal:  APMIS       Date:  2003-03       Impact factor: 3.205

View more
  3 in total

1.  Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.

Authors:  Theodore J Kottom; Deanne M Hebrink; Eva M Carmona; Andrew H Limper
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

Review 2.  Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.

Authors:  Adélaïde Chesnay; Christophe Paget; Nathalie Heuzé-Vourc'h; Thomas Baranek; Guillaume Desoubeaux
Journal:  J Fungi (Basel)       Date:  2022-01-27

3.  Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans.

Authors:  Theodore J Kottom; Eva M Carmona; Andrew H Limper
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.